Research Article

A Systems Pharmacology Approach for Identifying the Multiple Mechanisms of Action for the Rougui-Fuzi Herb Pair in the Treatment of Cardiocerebral Vascular Diseases

Table 1

The three centralities of 21 compounds were all higher than the average in C-T-D network.

MOL IDMolecule nameStructureDegree centrality (DC)Betweenness centrality (BC)Closeness centrality (CC)

MOL000675Oleic acid170.13940.4577
MOL002526δ-Guaijene80.02420.304
MOL000911Terpilene80.02480.3916
MOL000126(−)-Nopinene60.03980.4362
MOL000069Palmitic acid60.03320.3779
MOL000118(L)-Alpha-terpineol50.01190.3892
MOL000254Eugenol50.02970.4305
MOL003521Isohomogenol50.00830.3869
MOL000677(1R, 4R)-4-Isopropyl-1,6-dimethyltetralin50.00670.3916
MOL002392Deltoin50.00930.3916
MOL002417Fuzitine50.00860.3801
MOL000431Coumarin50.01270.3757
MOL003525Pyruvophenone50.02530.3631
MOL000198(R)-Linalool40.00750.3736
MOL000131Linoleic acid40.01810.414
MOL001393Myristic acid40.01460.3693
MOL000932Alpha-farnesene40.01210.3652
MOL000991Cinnamaldehyde40.01210.3652
MOL002295Cinnamic acid30.01410.4037
MOL000249Methylcinnamate30.01410.4037
MOL0035313-Methoxycinnamaldehyde30.01410.4037